VIYASH - Viyash Scientific

Viyash Scientific

VIYASH · Pharma > Pharmaceuticals & Drugs · Chairman: Kamal K Sharma · MD: Manish Gupta · Listing date: March 11, 2016 · Employees: 1770 · Bangalore · http://www.sequent.in

Stock Price vs Company Growth

1.4%

1.8%

12.4%

37.9%

35.3%

52.5%

0.6%

10y

7.2%

all

4.6%

🤔 How to analyze this graph?

Last Traded Price

₹ 283 1.4%

200

298

Company Overview

Sales

2,644 Cr

Growth: 21.8%

Profit after Tax

120 Cr

Growth: 189.9%

Mid Cap

12,361 Cr

P/E: 89.3x

Industry P/E: 33.7x

Fundamentals

Sales (Cr)	₹ 2,644
Growth	21.8%
EBITDA	17.7%
P/S	4.7x
Dividend	0.0%
P/E	89.3x
Book Value	₹ 66.6
PEG Ratio	4.2x
ROE	9.2%
P/B	4.3x

Shareholding Pattern

Institutions

Infinity Holdings

5.91 %

Unit Trust Of India Investment Advisory Services Limited A/C Ascent India Fund Iii

3.35 %

Ashoka India Opportunities Fund

1.35 %

Sbi Healthcare Opportunities Fund

1.21 %

Mukul Mahavir Agrawal

1.05 %

Promoters

Ca Harbor Investments

53.02 %

Chayadeep Ventures Llp

0.27 %

Rajitha Gopalakrishnan

0.2 %

Sajitha Pillai

0.15 %

Vineetha Mohanakumar Pillai

0.12 %

Others

Increase Decrease No change

Company Profile Detailed

Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd.

Belongs to (12 Indices) view more

Investors (91)

agnus.ho...

dilip.sh...

harish.n...

Followers (7)

jose4

joy2

ratnesh2